IGHE and asthma: A diagnosis of severe T2 asthma with overlap phenotype (high eosinophils and IgE levels with insect sensitization) was made and benralizumab 30 mg subcutaneously every 4 weeks, for three doses, followed by a dose every 8 weeks was prescribed to this patient.